Pro-Act.
Pro-Act., licence 80000213: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- 9764747 Canada Inc. dba New Herbal Magic
- NPN or DIN-HM
- 80000213
- Status
- Inactive licence
- Licence date
- 15 December 2004
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hypericum perforatum Rh | 250.0 mg | Not calculated |
Non-medicinal ingredients
cellulose, Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Helps to treat symptoms of sleep disorders. Traditionally used as sedative for relief of restlessness or nervousness
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid prolonged exposure to sunlight, ultraviolet light (UV) or UV therapy. Consult a health care practitioner if you are taking conventional medication such as contraceptives, HIV 1 protease inhibitors, non-nucleoside reverse transcriptase inhibitors, immunosuppresants, anticoagulants, digoxin, theophylline, serotonergic antidepressants, migraine therapies, SSRIs and/or anti-apilepsy drugs, if symptoms persist, or if you experience sleep disturbances.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80000213
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.